• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2023年欧洲心脏病学会心肌病管理指南:荷兰心血管病协会认可声明

2023 European Society of Cardiology guidelines on the management of cardiomyopathies : Statement of endorsement by the NVVC.

作者信息

Groeneweg Judith A, van Dalen Bas M, Cox Moniek P G J, Heymans Stephane, Braam Richard L, Michels Michelle, Asselbergs Folkert W

机构信息

Department of Cardiology, Diakonessenhuis, Utrecht, The Netherlands.

Department of Cardiology, Franciscus Gasthuis and Vlietland, Rotterdam, The Netherlands.

出版信息

Neth Heart J. 2025 May;33(5):148-156. doi: 10.1007/s12471-025-01955-2. Epub 2025 Apr 14.

DOI:10.1007/s12471-025-01955-2
PMID:40227490
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12014885/
Abstract

This article contextualises the 2023 European Society of Cardiology (ESC) guidelines for the management of cardiomyopathies for clinical practice in the Netherlands. The guideline addendum provides additional recommendations for situations where the ESC guidelines may not fully align with Dutch clinical practice. By endorsing the ESC guidelines through this addendum, the Netherlands Society of Cardiology (Nederlandse Vereniging Voor Cardiologie) supports its members in adhering to evidence-based management strategies for cardiomyopathies. As Dutch cardiologists generally adopt the ESC guidelines quickly, this contextualisation is essential for effective application thereof within the Dutch healthcare setting.

摘要

本文将2023年欧洲心脏病学会(ESC)心肌病管理指南置于荷兰临床实践的背景下进行阐述。该指南附录针对ESC指南可能与荷兰临床实践不完全相符的情况提供了补充建议。通过该附录认可ESC指南,荷兰心脏病学会(Nederlandse Vereniging Voor Cardiologie)支持其成员坚持采用基于证据的心肌病管理策略。由于荷兰心脏病专家通常会迅速采用ESC指南,因此这种背景阐述对于在荷兰医疗环境中有效应用该指南至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed28/12014885/228a76a69fc2/12471_2025_1955_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed28/12014885/1f0b58dd1836/12471_2025_1955_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed28/12014885/35cd927fdd46/12471_2025_1955_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed28/12014885/228a76a69fc2/12471_2025_1955_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed28/12014885/1f0b58dd1836/12471_2025_1955_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed28/12014885/35cd927fdd46/12471_2025_1955_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed28/12014885/228a76a69fc2/12471_2025_1955_Fig3_HTML.jpg

相似文献

1
2023 European Society of Cardiology guidelines on the management of cardiomyopathies : Statement of endorsement by the NVVC.2023年欧洲心脏病学会心肌病管理指南:荷兰心血管病协会认可声明
Neth Heart J. 2025 May;33(5):148-156. doi: 10.1007/s12471-025-01955-2. Epub 2025 Apr 14.
2
Genetic diagnostics and genetic counselling in Hypertrophic Cardiomyopathy (HCM).肥厚型心肌病(HCM)的遗传诊断和遗传咨询。
Neth Heart J. 2010 Mar;18(3):144-59. doi: 10.1007/BF03091753.
3
Continuing medical education in Europe: NVVC, CVOI, ESC, UEMS and EBAC.欧洲继续医学教育:荷兰继续医学教育协会、荷兰职业医学与工业卫生协会、欧洲心脏病学会、欧洲医学专家联盟和欧洲继续医学教育认证委员会。
Neth Heart J. 2001 Oct;9(7):288-291.
4
Specific recommendations (or lack thereof) for older patients with cardiovascular disease in the current European Society of Cardiology guidelines : From the Dutch Working Group of Geriatric Cardiology of the Netherlands Society of Cardiology (NVVC) and Special Interest Group Geriatric Cardiology of the Netherlands Society for Clinical Geriatrics (NVKG).欧洲心脏病学会现行指南中针对老年心血管疾病患者的具体建议(或缺乏此类建议):来自荷兰心脏病学会老年心脏病学荷兰工作组(NVVC)以及荷兰临床老年医学学会老年心脏病学特别兴趣小组(NVKG)
Neth Heart J. 2022 Dec;30(12):541-545. doi: 10.1007/s12471-022-01674-y. Epub 2022 Mar 31.
5
2021 European Society of Cardiology guidelines on cardiac pacing and cardiac resynchronisation therapy : Statement of endorsement by the NVVC.2021年欧洲心脏病学会心脏起搏与心脏再同步治疗指南:荷兰心脏起搏与心脏电生理学会认可声明
Neth Heart J. 2025 Feb;33(2):38-45. doi: 10.1007/s12471-024-01927-y. Epub 2025 Jan 21.
6
2023 European Society of Cardiology guidelines for the management of acute coronary syndromes : Statement of endorsement by the NVVC.2023年欧洲心脏病学会急性冠状动脉综合征管理指南:荷兰心血管病协会认可声明
Neth Heart J. 2024 Oct;32(10):338-345. doi: 10.1007/s12471-024-01896-2. Epub 2024 Sep 10.
7
The new European Society of Cardiology guideline for the management of cardiomyopathies: key messages for cardiac electrophysiologists.欧洲心脏病学会心肌病管理新指南:心脏电生理学家的关键信息。
Herzschrittmacherther Elektrophysiol. 2023 Dec;34(4):311-323. doi: 10.1007/s00399-023-00975-y. Epub 2023 Nov 16.
8
[Management of cardiomyopathies : New ESC guidelines 2023].[心肌病的管理:2023年欧洲心脏病学会新指南]
Herz. 2024 Feb;49(1):22-32. doi: 10.1007/s00059-023-05224-z. Epub 2023 Dec 5.
9
Translating the 2021 ESC heart failure guideline recommendations in daily practice: Results from a heart failure survey. A scientific statement of the ESC Council for Cardiology Practice and the Heart Failure Association of the ESC.在日常实践中落实2021年欧洲心脏病学会(ESC)心力衰竭指南建议:一项心力衰竭调查结果。ESC心脏病学实践委员会和ESC心力衰竭协会的科学声明
Eur J Heart Fail. 2025 Mar;27(3):412-420. doi: 10.1002/ejhf.3444. Epub 2024 Sep 24.
10
2020 ESC Guidelines on acute coronary syndrome without ST-segment elevation : Recommendations and critical appraisal from the Dutch ACS and Interventional Cardiology working groups.2020年欧洲心脏病学会非ST段抬高型急性冠状动脉综合征指南:荷兰急性冠状动脉综合征及介入心脏病学工作组的建议与批判性评估
Neth Heart J. 2021 Nov;29(11):557-565. doi: 10.1007/s12471-021-01593-4. Epub 2021 Jul 7.

引用本文的文献

1
A Narrative Review of Current and Investigational Therapies in Hypertrophic Cardiomyopathy.肥厚型心肌病当前及研究性治疗的叙述性综述
Biomedicines. 2025 May 29;13(6):1327. doi: 10.3390/biomedicines13061327.
2
Cardiomyopathy care and real-world practice in the Netherlands.荷兰的心肌病护理与实际医疗实践。
Neth Heart J. 2025 May;33(5):147. doi: 10.1007/s12471-025-01956-1. Epub 2025 Apr 22.

本文引用的文献

1
2021 European Society of Cardiology guidelines on cardiac pacing and cardiac resynchronisation therapy : Statement of endorsement by the NVVC.2021年欧洲心脏病学会心脏起搏与心脏再同步治疗指南:荷兰心脏起搏与心脏电生理学会认可声明
Neth Heart J. 2025 Feb;33(2):38-45. doi: 10.1007/s12471-024-01927-y. Epub 2025 Jan 21.
2
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC.2023 年 ESC 急性和慢性心力衰竭诊断和治疗指南的重点更新:由欧洲心脏病学会(ESC)急性和慢性心力衰竭诊断和治疗工作组制定,ESC 心力衰竭协会(HFA)特别贡献。
Eur J Heart Fail. 2024 Jan;26(1):5-17. doi: 10.1002/ejhf.3024. Epub 2024 Jan 3.
3
2023 ESC Guidelines for the management of cardiomyopathies.2023年欧洲心脏病学会心肌病管理指南。
Eur Heart J. 2023 Oct 1;44(37):3503-3626. doi: 10.1093/eurheartj/ehad194.
4
A randomized controlled trial of eplerenone in asymptomatic phospholamban p.Arg14del carriers.依普利酮用于无症状磷酸受磷蛋白p.Arg14del携带者的随机对照试验。
Eur Heart J. 2023 Oct 21;44(40):4284-4287. doi: 10.1093/eurheartj/ehad292.
5
Timing of cardioverter-defibrillator implantation in patients with cardiac laminopathies-External validation of the LMNA-risk ventricular tachyarrhythmia calculator.心脏肌原病患者心脏转复除颤器植入的时机-LMNA 风险室性心律失常计算器的外部验证。
Heart Rhythm. 2023 Mar;20(3):423-429. doi: 10.1016/j.hrthm.2022.11.024. Epub 2022 Dec 6.
6
2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death.2022年欧洲心脏病学会室性心律失常患者管理和心脏性猝死预防指南
Eur Heart J. 2022 Oct 21;43(40):3997-4126. doi: 10.1093/eurheartj/ehac262.
7
2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy.2021年欧洲心脏病学会心脏起搏与心脏再同步治疗指南。
Eur Heart J. 2021 Sep 14;42(35):3427-3520. doi: 10.1093/eurheartj/ehab364.
8
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.2021年欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南。
Eur Heart J. 2021 Sep 21;42(36):3599-3726. doi: 10.1093/eurheartj/ehab368.
9
Prediction of ventricular arrhythmia in phospholamban p.Arg14del mutation carriers-reaching the frontiers of individual risk prediction.磷酸化酶脑肌磷酸酶辅因子 1 基因 p.Arg14del 突变携带者室性心律失常的预测——个体风险预测的前沿。
Eur Heart J. 2021 Jul 31;42(29):2842-2850. doi: 10.1093/eurheartj/ehab294.
10
Expert consensus on the monitoring of transthyretin amyloid cardiomyopathy.关于转甲状腺素蛋白淀粉样心肌病监测的专家共识。
Eur J Heart Fail. 2021 Jun;23(6):895-905. doi: 10.1002/ejhf.2198. Epub 2021 May 24.